243 related articles for article (PubMed ID: 21487040)
1. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.
Hu X; Yang D; Zimmerman M; Liu F; Yang J; Kannan S; Burchert A; Szulc Z; Bielawska A; Ozato K; Bhalla K; Liu K
Cancer Res; 2011 Apr; 71(8):2882-91. PubMed ID: 21487040
[TBL] [Abstract][Full Text] [Related]
2. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.
Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T
PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407
[TBL] [Abstract][Full Text] [Related]
3. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.
Huang W; Zhu C; Wang H; Horvath E; Eklund EA
J Biol Chem; 2008 Mar; 283(12):7921-35. PubMed ID: 18195016
[TBL] [Abstract][Full Text] [Related]
4. IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression.
Yang D; Thangaraju M; Browning DD; Dong Z; Korchin B; Lev DC; Ganapathy V; Liu K
J Immunol; 2007 Oct; 179(7):4775-82. PubMed ID: 17878376
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance.
Scheller M; Schönheit J; Zimmermann K; Leser U; Rosenbauer F; Leutz A
J Exp Med; 2013 Oct; 210(11):2239-56. PubMed ID: 24101380
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor IRF8 counteracts BCR-ABL to rescue dendritic cell development in chronic myelogenous leukemia.
Watanabe T; Hotta C; Koizumi S; Miyashita K; Nakabayashi J; Kurotaki D; Sato GR; Yamamoto M; Nakazawa M; Fujita H; Sakai R; Fujisawa S; Nishiyama A; Ikezawa Z; Aihara M; Ishigatsubo Y; Tamura T
Cancer Res; 2013 Nov; 73(22):6642-53. PubMed ID: 24242069
[TBL] [Abstract][Full Text] [Related]
7. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
Hjort EE; Huang W; Hu L; Eklund EA
Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
[TBL] [Abstract][Full Text] [Related]
8. Regulation of myelopoiesis by the transcription factor IRF8.
Tamura T; Kurotaki D; Koizumi S
Int J Hematol; 2015 Apr; 101(4):342-51. PubMed ID: 25749660
[TBL] [Abstract][Full Text] [Related]
9. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
Hao SX; Ren R
Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells.
Yang J; Hu X; Zimmerman M; Torres CM; Yang D; Smith SB; Liu K
J Immunol; 2011 Nov; 187(9):4426-30. PubMed ID: 21949018
[TBL] [Abstract][Full Text] [Related]
11. IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression.
Yang D; Wang S; Brooks C; Dong Z; Schoenlein PV; Kumar V; Ouyang X; Xiong H; Lahat G; Hayes-Jordan A; Lazar A; Pollock R; Lev D; Liu K
Cancer Res; 2009 Feb; 69(3):1080-8. PubMed ID: 19155307
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.
Hu X; Bardhan K; Paschall AV; Yang D; Waller JL; Park MA; Nayak-Kapoor A; Samuel TA; Abrams SI; Liu K
J Biol Chem; 2013 Jun; 288(26):19103-15. PubMed ID: 23677993
[TBL] [Abstract][Full Text] [Related]
13. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.
Selleri C; Maciejewski JP; Pane F; Luciano L; Raiola AM; Mostarda I; Salvatore F; Rotoli B
Blood; 1998 Aug; 92(3):981-9. PubMed ID: 9680367
[TBL] [Abstract][Full Text] [Related]
16. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
17. Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.
Lickliter JD; Kratzke RA; Nguyen PL; Niehans GA; Miller JS
Exp Hematol; 1999 Oct; 27(10):1519-27. PubMed ID: 10517493
[TBL] [Abstract][Full Text] [Related]
18. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
[TBL] [Abstract][Full Text] [Related]
19. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
